258 related articles for article (PubMed ID: 29243485)
1. Molecular imaging of prostate cancer.
Boustani AM; Pucar D; Saperstein L
Br J Radiol; 2018 Apr; 91(1084):20170736. PubMed ID: 29243485
[TBL] [Abstract][Full Text] [Related]
2. Clinical Applications of Molecular Imaging in the Management of Prostate Cancer.
Gorin MA; Rowe SP; Denmeade SR
PET Clin; 2017 Apr; 12(2):185-192. PubMed ID: 28267452
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging for Primary Staging of Prostate Cancer.
Pomykala KL; Farolfi A; Hadaschik B; Fendler WP; Herrmann K
Semin Nucl Med; 2019 Jul; 49(4):271-279. PubMed ID: 31227050
[TBL] [Abstract][Full Text] [Related]
4. Molecular Imaging of Recurrent and Metastatic Prostate Cancer.
Ware RE; Williams S; Hicks RJ
Semin Nucl Med; 2019 Jul; 49(4):280-293. PubMed ID: 31227051
[TBL] [Abstract][Full Text] [Related]
5. The timing of molecular imaging in prostate cancer.
Morris MJ
Clin Adv Hematol Oncol; 2018 Mar; 16(3):195-197. PubMed ID: 29742075
[No Abstract] [Full Text] [Related]
6. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
7. Oligometastatic prostate cancer: shaping the definition with molecular imaging and an improved understanding of tumor biology.
Joice GA; Rowe SP; Pienta KJ; Gorin MA
Curr Opin Urol; 2017 Nov; 27(6):533-541. PubMed ID: 28863016
[TBL] [Abstract][Full Text] [Related]
8. Functional and molecular imaging: applications for diagnosis and staging of localised prostate cancer.
Turkbey B; Mena E; Aras O; Garvey B; Grant K; Choyke PL
Clin Oncol (R Coll Radiol); 2013 Aug; 25(8):451-60. PubMed ID: 23722008
[TBL] [Abstract][Full Text] [Related]
9. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
10. [MRI of the prostate].
Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status.
Quesada-Olarte JM; Allaf ME; Alvarez-Maestro M; Martínez-Piñeiro L
Actas Urol Esp (Engl Ed); 2020; 44(6):386-399. PubMed ID: 32709428
[TBL] [Abstract][Full Text] [Related]
12. Intraprostatic targeting.
Ukimura O; Faber K; Gill IS
Curr Opin Urol; 2012 Mar; 22(2):97-103. PubMed ID: 22249373
[TBL] [Abstract][Full Text] [Related]
13. The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory.
Sathianathen NJ; Geurts N; Nair R; Lawrentschuk N; Murphy DG; Lamb AD
Future Oncol; 2017 Aug; 13(20):1801-1807. PubMed ID: 28762288
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.
Recabal P; Assel M; Sjoberg DD; Lee D; Laudone VP; Touijer K; Eastham JA; Vargas HA; Coleman J; Ehdaie B
J Urol; 2016 Aug; 196(2):374-81. PubMed ID: 26920465
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.
Gupta RT; Spilseth B; Patel N; Brown AF; Yu J
Abdom Radiol (NY); 2016 May; 41(5):831-43. PubMed ID: 27193786
[TBL] [Abstract][Full Text] [Related]
16. Molecular Imaging of Prostate Cancer.
Wibmer AG; Burger IA; Sala E; Hricak H; Weber WA; Vargas HA
Radiographics; 2016; 36(1):142-59. PubMed ID: 26587888
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.
Schiavina R; Chessa F; Borghesi M; Gaudiano C; Bianchi L; Corcioni B; Castellucci P; Ceci F; Ceravolo I; Barchetti G; Del Monte M; Campa R; Catalano C; Panebianco V; Nanni C; Fanti S; Minervini A; Porreca A; Brunocilla E
Int J Urol; 2019 Jan; 26(1):18-30. PubMed ID: 30238516
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
[TBL] [Abstract][Full Text] [Related]
19. Management of biochemically recurrent prostate cancer: molecular imaging perspective.
Lorca AM
World J Urol; 2018 Feb; 36(2):321-322. PubMed ID: 29134278
[No Abstract] [Full Text] [Related]
20. Dynamic Contrast-Enhanced Imaging as a Prognostic Tool in Early Diagnosis of Prostate Cancer: Correlation with PSA and Clinical Stage.
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Contrast Media Mol Imaging; 2018; 2018():3181258. PubMed ID: 30327584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
